Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCanal+ Regulatory News (CAN)

Share Price Information for Canal+ (CAN)

Share Price is delayed by 15 minutes
Get Live Data
263.80    -6.80 (-2.51%)
Bid:
264.60
Ask:
265.00
Spread: 0.40 (0.151%)
Market Cap: £2.59b
CAN Live PriceLast checked at - London Stock Exchange

Intraday Canal+ Share Chart

Holding(s) in Company

17 Apr 2025 10:47

RNS Number : 4834F
Canal+ S.A
17 April 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

FR001400T0D6

Issuer Name

CANAL+

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights; Other

Comments

Application of Trading Book Exemption (see Section 11 below)

3. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

Name

City of registered office

Country of registered office

Morgan Stanley

Wilmington, Delaware

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

10-Apr-2025

6. Date on which Issuer notified

15-Apr-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

0.000000

0.000000

0

Position of previous notification (if applicable)

5.073797

0.055226

5.129023

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

FR001400T0D6

0

0.000000

Sub Total 8.A

0

0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

.

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

The notification was triggered due to Morgan Stanley's total applicable holding dropping below 5%. As a result, Morgan Stanley has applied the trading book exemption (DTR 5.1.3R(4)) to its remaining applicable holding of 4.630303% as of April 10,2025.

12. Date of Completion

15-Apr-2025

13. Place Of Completion

Mumbai

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUBSKRVUUSARR
Date   Source Headline
8th Jun 20268:00 amRNSDIVIDEND CURRENCY CONVERSION ANNOUNCEMENT
2nd Jun 20269:26 amRNSHolding(s) in Company
1st Jun 20265:27 pmRNSAPPOINTMENTS TO THE SUPERVISORY BOARD
29th May 20266:07 pmRNSResults of Combined Shareholders' General Meeting
27th May 20263:00 pmRNSHolding(s) in Company
18th May 20266:28 pmRNSPublication of the Final Information Memorandum
13th May 20266:28 pmRNS€700 MILLION BOND ISSUE SUCCESSFULLY PRICED
13th May 20264:00 pmRNSStabilisation Notice- CANAL+
13th May 20263:37 pmRNSConvening Brochure - Shareholders’ General Meeting
13th May 20268:58 amRNSStabilisation Notice- CANAL +
12th May 20265:17 pmRNSHolding(s) in Company
12th May 20267:05 amRNSSECONDARY INWARD LISTING ON THE JSE
11th May 20269:23 amRNSPOTENTIAL BOND TRANSACTION
28th Apr 20267:00 amRNSCANAL+ Q1 2026 Trading Update
17th Apr 20261:05 pmRNSDirector Declaration
20th Mar 20263:38 pmRNSDirector/PDMR Shareholding
17th Mar 20263:28 pmRNSDirector/PDMR Shareholding
17th Mar 20263:26 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSAnnual Financial Report
17th Mar 20267:00 amRNSAnnual Financial Report
12th Mar 20264:14 pmRNSDirector/PDMR Shareholding
12th Mar 20264:11 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNS2025 FY Preliminary Results & Strategic Update
11th Mar 20267:00 amRNS2025 FY Preliminary Results & Strategic Update
5th Mar 20267:10 amRNSMCG RETIRES SHOWMAX AFTER COMPREHENSIVE REVIEW
27th Feb 20261:22 pmRNSDirector Declaration
12th Feb 20263:47 pmRNSHolding(s) in Company
11th Feb 20263:06 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSCANAL+ MULTICHOICE SYNERGIES UPDATE
28th Jan 20262:42 pmRNSHolding(s) in Company
26th Jan 20269:09 amRNSDate of communication on MCG acquisition synergies
23rd Jan 20264:44 pmRNSHolding(s) in Company
6th Jan 20264:02 pmRNSHolding(s) in Company
2nd Jan 20262:43 pmRNSHolding(s) in Company
2nd Jan 202610:40 amRNSHolding(s) in Company
2nd Jan 202610:37 amRNSHolding(s) in Company
2nd Jan 202610:09 amRNSTotal Voting Rights
19th Dec 202510:30 amRNSRESOLUTION OF FRENCH VAT DISPUTE
19th Dec 202510:30 amRNSRESOLUTION OF FRENCH VAT DISPUTE
18th Dec 20255:00 pmRNSSUCCESSFUL EUR 1.8 BILLION FINANCING AGREEMENT
18th Dec 20255:00 pmRNSSUCCESSFUL EUR 1.8 BILLION FINANCING AGREEMENT
11th Dec 20252:24 pmRNSPost-Stabilisation Notice- Canal +
8th Dec 20252:15 pmRNSTERMINATION OF MULTICHOICE JSE AND A2X LISTINGS
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:34 pmRNSPUBLICATION OF THE FINAL INFORMATION MEMORANDUM
1st Dec 20252:13 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20255:21 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNS€700 MILLION BOND ISSUE SUCCESSFULLY PRICED

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.